CVS — CVS HEALTH CORP

Ownership history in Freestone Grove Partners LP  ·  5 quarters on record

This page tracks every 13F SEC filing in which Freestone Grove Partners LP reported a position in CVS HEALTH CORP (CVS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.7% (2025 Q3)
Avg. % of fund
0.62%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,112,239 -134,083 -10.8% 0.64% $88.3M $78.71
2025 Q3 REDUCED 1,246,322 -1,216 -0.1% 0.70% $94.0M $74.17
2025 Q2 ADDED 1,247,538 +284,342 +29.5% 0.65% $86.1M $67.13
2025 Q1 ADDED 963,196 +156,621 +19.4% 0.67% $65.3M $65.26
2024 Q4 INITIATED 806,575 — — 0.44% $36.2M $42.70
% of Fund (quarterly)    CVS price (monthly, adj. close)

Other funds also holding CVS

As of 2025 Q4 — sorted by position size

Watchtower Advisors, LP 3Y 17.11% GLENVIEW CAPITAL MANAGEMENT, LLC 3Y 7Y 13.24% FAIRFAX FINANCIAL HOLDINGS LTD/ CAN 3Y 7Y 10.33% Solel Partners LP 3Y 7.62% Kiltearn Partners LLP 3Y 7Y 7.59% Chieftain Capital Management, Inc. 3Y 7Y 6.9% EDGAR LOMAX CO/VA 3Y 7Y 5.5% COLRAIN CAPITAL LLC 3Y 7Y 5.34% Sachem Head Capital Management LP 3Y 7Y 4.81% 8 KNOTS MANAGEMENT, LLC 4.71%
← Back to Freestone Grove Partners LP Holdings